1. School of Cardiovascular and Metabolic Health, British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (M.C.P., J.J.V.M.).
2. Montréal Heart Institute, University of Montréal, Quebec, Canada (J.L.R.).
3. Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (B.C., K.J., Z.M.M., E.B., S.D.S., M.A.P.).
4. Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (P.v.d.M.).
5. Duke University Medical Center, Durham, NC (C.G.).
6. Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, South Australia, Flinders University (C.G.D.P.).
7. Washington University Medical Center, St Louis, MO (D.M.).
8. Université Paris-Cité, Assistance Publique-Hôpitaux de Paris, French Alliance for Cardiovascular Trials, INSERM U-1148, France (P.G.S.).
9. ANMCO Research Center, Florence, Italy (A.M.).
10. Heart Institute, Hadassah University Hospital, Jerusalem, Israel (O.A.).
11. Novartis Pharmaceutical Corporation, East Hanover, NJ (M.L.).